BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 9767632)

  • 1. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.
    Artico M; Di Santo R; Costi R; Novellino E; Greco G; Massa S; Tramontano E; Marongiu ME; De Montis A; La Colla P
    J Med Chem; 1998 Oct; 41(21):3948-60. PubMed ID: 9767632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
    Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
    J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
    King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
    J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chicoric acid analogues as HIV-1 integrase inhibitors.
    Lin Z; Neamati N; Zhao H; Kiryu Y; Turpin JA; Aberham C; Strebel K; Kohn K; Witvrouw M; Pannecouque C; Debyser Z; De Clercq E; Rice WG; Pommier Y; Burke TR
    J Med Chem; 1999 Apr; 42(8):1401-14. PubMed ID: 10212126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines.
    Brzozowski Z; Saczewski F; Sanchez T; Kuo CL; Gdaniec M; Neamati N
    Bioorg Med Chem; 2004 Jul; 12(13):3663-72. PubMed ID: 15186851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays.
    Costi R; Di Santo R; Artico M; Roux A; Ragno R; Massa S; Tramontano E; La Colla M; Loddo R; Marongiu ME; Pani A; La Colla P
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1745-9. PubMed ID: 15026063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells.
    Mekouar K; Mouscadet JF; Desmaële D; Subra F; Leh H; Savouré D; Auclair C; d'Angelo J
    J Med Chem; 1998 Jul; 41(15):2846-57. PubMed ID: 9667973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
    Dayam R; Sanchez T; Clement O; Shoemaker R; Sei S; Neamati N
    J Med Chem; 2005 Jan; 48(1):111-20. PubMed ID: 15634005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
    Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
    J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors.
    Meadows DC; Mathews TB; North TW; Hadd MJ; Kuo CL; Neamati N; Gervay-Hague J
    J Med Chem; 2005 Jul; 48(14):4526-34. PubMed ID: 15999991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
    Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
    Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activity.
    Di Santo R; Costi R; Artico M; Ragno R; Greco G; Novellino E; Marchand C; Pommier Y
    Farmaco; 2005 May; 60(5):409-17. PubMed ID: 15910813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationally designed dual inhibitors of HIV reverse transcriptase and integrase.
    Wang Z; Bennett EM; Wilson DJ; Salomon C; Vince R
    J Med Chem; 2007 Jul; 50(15):3416-9. PubMed ID: 17608468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
    Neamati N; Hong H; Mazumder A; Wang S; Sunder S; Nicklaus MC; Milne GW; Proksa B; Pommier Y
    J Med Chem; 1997 Mar; 40(6):942-51. PubMed ID: 9083483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel thiazolothiazepine based HIV-1 integrase inhibitors.
    Aiello F; Brizzi A; Garofalo A; Grande F; Ragno G; Dayam R; Neamati N
    Bioorg Med Chem; 2004 Aug; 12(16):4459-66. PubMed ID: 15265496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
    Verschueren WG; Dierynck I; Amssoms KI; Hu L; Boonants PM; Pille GM; Daeyaert FF; Hertogs K; Surleraux DL; Wigerinck PB
    J Med Chem; 2005 Mar; 48(6):1930-40. PubMed ID: 15771437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
    Fattorusso C; Gemma S; Butini S; Huleatt P; Catalanotti B; Persico M; De Angelis M; Fiorini I; Nacci V; Ramunno A; Rodriquez M; Greco G; Novellino E; Bergamini A; Marini S; Coletta M; Maga G; Spadari S; Campiani G
    J Med Chem; 2005 Nov; 48(23):7153-65. PubMed ID: 16279773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo design and synthesis of HIV-1 integrase inhibitors.
    Makhija MT; Kasliwal RT; Kulkarni VM; Neamati N
    Bioorg Med Chem; 2004 May; 12(9):2317-33. PubMed ID: 15080929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors.
    Sechi M; Derudas M; Dallocchio R; Dessì A; Bacchi A; Sannia L; Carta F; Palomba M; Ragab O; Chan C; Shoemaker R; Sei S; Dayam R; Neamati N
    J Med Chem; 2004 Oct; 47(21):5298-310. PubMed ID: 15456274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5.
    Bodiwala HS; Sabde S; Gupta P; Mukherjee R; Kumar R; Garg P; Bhutani KK; Mitra D; Singh IP
    Bioorg Med Chem; 2011 Feb; 19(3):1256-63. PubMed ID: 21227704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.